<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05092152</url>
  </required_header>
  <id_info>
    <org_study_id>PROMINA</org_study_id>
    <nct_id>NCT05092152</nct_id>
  </id_info>
  <brief_title>Propofol Versus Esketamine for Rapid Sequence Intubation in Critically Ill Patients</brief_title>
  <acronym>PROMINA</acronym>
  <official_title>Propofol Versus Esketamine for Rapid Sequence Intubation in Critically Ill Patients: A Randomized, Multicenter, Unblinded, Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Federal University of São Paulo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Federal University of São Paulo</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Rapid-sequence intubation is routinely performed in critically ill patients. It is unclear&#xD;
      whether different sedative agents may influence short-term outcomes after intubation,&#xD;
      specially hemodynamic stability.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 2021</start_date>
  <completion_date type="Anticipated">December 2024</completion_date>
  <primary_completion_date type="Anticipated">September 2024</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Lowest mean blood pressure</measure>
    <time_frame>Ten minutes after induction</time_frame>
    <description>Lowest mean blood pressure</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Early death</measure>
    <time_frame>One hour</time_frame>
    <description>Death within one hour of intubation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiac arrest</measure>
    <time_frame>One hour</time_frame>
    <description>Cardiac arrest requiring resuscitation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Severe hypotension</measure>
    <time_frame>One hour</time_frame>
    <description>Systolic blood pressure below 80 mmHg</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Severe hypoxemia</measure>
    <time_frame>One hour</time_frame>
    <description>Peripheral oxygen saturation below 85%</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of intubation attempts</measure>
    <time_frame>One hour</time_frame>
    <description>Number of attempts</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Cumulative vasopressor use</measure>
    <time_frame>24 hours after intubation</time_frame>
    <description>Cumulative, in milligrams, dose of vasopressors used</description>
  </other_outcome>
  <other_outcome>
    <measure>Maximum heart rate</measure>
    <time_frame>One hour</time_frame>
    <description>Maximum heart rate</description>
  </other_outcome>
  <other_outcome>
    <measure>Days alive and free of mechanical ventilation</measure>
    <time_frame>Seven days</time_frame>
    <description>Days patient spend alive and free of mechanical ventilation in the first seven days after intubation</description>
  </other_outcome>
  <other_outcome>
    <measure>Mortality in the Intensive Care Unit</measure>
    <time_frame>28 days</time_frame>
    <description>Mortality in the Intensive Care Unit</description>
  </other_outcome>
  <other_outcome>
    <measure>Mortality in hospital</measure>
    <time_frame>28 days</time_frame>
    <description>Mortality in hospital</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">170</enrollment>
  <condition>Acute Respiratory Failure</condition>
  <arm_group>
    <arm_group_label>Propofol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Esketamina</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Esketamine hydrochloride</intervention_name>
    <description>2 mg per kilogram of body weight</description>
    <arm_group_label>Esketamina</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propofol</intervention_name>
    <description>1.5 mg per kilogram of body weight</description>
    <arm_group_label>Propofol</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age above 18 years old&#xD;
&#xD;
          -  Physician indicated intubation&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Intubation during cardiac arrest&#xD;
&#xD;
          -  Known of suspected intracranial hypertension&#xD;
&#xD;
          -  Known allergy to propofol or esketamine&#xD;
&#xD;
          -  Bradycardia (heart rate below 50 beats per minute) or atrioventricular block&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Flavia R Machado, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Federal University of São Paulo</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Raysa Schmidt, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Federal University of São Paulo</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Raysa Schmidt, MD</last_name>
    <phone>+551155764848</phone>
    <email>csraysa@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Flavia R Machado, MD, PhD</last_name>
    <phone>+551155764848</phone>
    <phone_ext>17018</phone_ext>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Federal University of São Paulo</name>
      <address>
        <city>São Paulo</city>
        <zip>04038002</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <contact>
      <last_name>Raysa Schmidt, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>October 13, 2021</study_first_submitted>
  <study_first_submitted_qc>October 13, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 25, 2021</study_first_posted>
  <last_update_submitted>October 24, 2021</last_update_submitted>
  <last_update_submitted_qc>October 24, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 29, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Federal University of São Paulo</investigator_affiliation>
    <investigator_full_name>Flavia Ribeiro Machado</investigator_full_name>
    <investigator_title>Chair of Critical Care Department</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Insufficiency</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Esketamine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_time_frame>6 months after trial finished enrolling</ipd_time_frame>
    <ipd_access_criteria>Upon reasonable request</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

